Kevin Lee, CHIEF EXECUTIVE OFFICER at BICYCLE THERAPEUTICS PLC (BCYC), sold 21,168 shares at $14.09 ($300K) on 2025-01-02, disclosed to the SEC on 2025-01-06.
Seasonal sale ($300k) by CHIEF EXECUTIVE OFFICER — this insider has traded BCYC in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.09 | 9,038 | $127K | 42.4% |
| 2 | $14.09 | 9,038 | $127K | 42.4% |
| 3 | $14.75 | 3,092 | $46K | 15.2% |
| Total | $14.19 avg | 21,168 | $300K | 100% |
| Filing → |
| BCYC | SELL | 2026-04-06 | $38K | — | Filing → |
| BCYC | SELL | 2026-01-06 | $141K | — | Filing → |
| BCYC | SELL | 2025-10-06 | $46K | — | Filing → |